LEEDERVILLE-BASED Pharmanet Group Ltd has announced positive results from research into its protein fragment drug, which inhibits reaction to UVB burns.
20/12/2005 - 21:00
Pharmanet claims burns trial success
20/12/2005 - 21:00
